A new multiplex immunofluorescence workflow using standard laboratory equipment and open-source software enables detailed ...
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
KATY, TX / ACCESS Newswire / July 1, 2026 / In the wave of precision medicine development and accelerated iteration of life science technology, immunofluorescence (IF) technology has become a core sup ...
Spatial biology technologies are reshaping modern biomedical research by enabling the visualization of cellular organization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results